Biotech Acquisition Company Cl A (BIOT)
Biotech Acquisition Company Cl A (BIOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 936 | 677 | N/A | N/A |
| Other current assets | 0 | 25 | 0 | 0 |
| TOTAL | $1,277 | $1,500 | $N/A | $N/A |
| Non-Current Assets | ||||
| Investments And Advances | 230,010 | 230,004 | 0 | 0 |
| TOTAL | $230,010 | $230,004 | $N/A | $N/A |
| Total Assets | $231,286 | $231,504 | $N/A | $90 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 331 | 81 | 0 | 0 |
| Accrued Expenses | N/A | 11 | N/A | N/A |
| TOTAL | $331 | $92 | $N/A | $70 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 225,955 | 226,413 | 0 | 0 |
| TOTAL | $225,955 | $226,413 | $N/A | $N/A |
| Total Liabilities | $226,286 | $226,504 | $N/A | $70 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,750 | 28,750 | 28,750 | 28,750 |
| Common Shares | 1 | 0 | N/A | 1 |
| Retained earnings | -2,526 | 2,542 | N/A | -5 |
| Other shareholders' equity | 0 | 1 | 0 | 0 |
| TOTAL | $5,000 | $5,000 | $N/A | $20 |
| Total Liabilities And Equity | $231,286 | $231,504 | $0 | $90 |